ArticleJournal of cell science2026
Regulation of Citron kinase by CDK1 and Aurora B regulates midbody formation and stability.
Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Citron Kinase, a mitotic kinase with increasing significance in cancer.Cell cycle (Georgetown, Tex.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Many cell division events are regulated by protein phosphorylation, which can result from cross-regulatory mechanisms among mitotic kinases and phosphatases that have yet to be fully elucidated. Here, we report the characterization of a novel mechanism by which CDK1 and Aurora B (AURKB) kinases regulate the distribution and interactions of Citron kinase (CIT-K, encoded by CIT). We show that CDK1 phosphorylates serine 440 and AURKB phosphorylates serine 699, both residues located adjacent to or within the CIT-K coiled coil domain. S440 and S699 temporal phosphorylation profiles reflect the activity of the kinases responsible for their phosphorylation. Functional analyses using phosphorylation site mutants indicate that S699 phosphorylation is important for CIT-K localization and successful cytokinesis, whereas perturbing S440 phosphorylation leads to abnormal midbody formation and accumulation of post-mitotic midbody remnants (MBRs). Furthermore, we found that phosphorylation at either residue reduces the ability of CIT-K to interact with its midbody partners AURKB, KIF14 and MKLP1 (also known as KIF23). Taken together, our findings indicate that phosphorylation of CIT-K by CDK1 and AURKB regulates midbody formation and MBR stability by controlling the association of CIT-K with its partners. They expand our understanding of the mechanisms that regulate abscission and can lead to further insights into the role of MBRs in post-mitotic events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.